Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy
Yuni Yun (Yun Y), Dongsub Kim (Kim D), Yun-Jeong Lee (Lee YJ), Soonhak Kwon (Kwon S), Su-Kyeong Hwang (Hwang SK)
Clin Exp Pediatr. 2019;62(7):269-273.   Published online 2018 Dec 26     DOI: https://doi.org/10.3345/kjp.2018.06863
Citations to this article as recorded by Crossref logo
Efficacy and safety of perampanel for the treatment of epilepsy in adolescents: a meta-analysis
Ting Wang, Limin Li, Fei Sun, Yonghua Yang, Xiaohong Liu
International Journal of Neuroscience.2022; : 1.     CrossRef
Perampanel markedly improved clinical seizures in a patient with a Rett‐like phenotype and 960‐kb deletion on chromosome 9q34.11 including the STXBP1
Syun Yoshida, Masano Amamoto, Tomoyuki Takahashi, Ichiro Tomita, Kotaro Yuge, Munetsugu Hara, Kazuhiro Iwama, Naomichi Matsumoto, Toyojiro Matsuishi
Clinical Case Reports.2022;[Epub]     CrossRef
Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: A multicenter observational study in Thailand
Piradee Suwanpakdee, Burachat Saksritavee, Napakjira Likasitthananon, Thitiwan Simasathien, Tayard Deesudchit, Chaiyos Khongkhatithum, Sorawit Viravan, Charcrin Nabangchang
Seizure.2022; 100: 103.     CrossRef
Efficacy and tolerability of perampanel as adjunctive treatment of focal and generalized tonic-clonic epileptic seizures in children over 4 years of age
E.D. Belousova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakov.2021; 121(3): 116.     CrossRef
Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children
Jon Soo Kim, Won Seop Kim
Korean Journal of Pediatrics.2019; 62(7): 259.     CrossRef
Perampanel
Reactions Weekly.2019; 1774(1): 266.     CrossRef